BTI-322 rat monoclonal antibody targeting the CD2 molecule on T and NK cells: Phase II testing

MedImmune Inc. (MEDI), Gaithersburg, Md.
Product:

Read the full 66 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE